Cantor Fitzgerald set a $310.00 price target on UnitedHealth Group (NYSE:UNH) in a research note released on Friday morning, TipRanks reports. The brokerage currently has a buy rating on the healthcare conglomerate’s stock. Cantor Fitzgerald also issued estimates for UnitedHealth Group’s FY2019 earnings at $14.82 EPS and FY2020 earnings at $16.80 EPS.
Several other equities analysts have also recently weighed in on the company. Citigroup reissued a buy rating on shares of Healthequity in a research report on Friday, May 10th. Zacks Investment Research raised Falcon Minerals from a sell rating to a hold rating in a research report on Monday. UBS Group set a $36.00 price objective on Halliburton and gave the stock a buy rating in a research report on Tuesday, April 23rd. Raymond James reissued a buy rating on shares of West Fraser Timber in a research report on Friday. Finally, ValuEngine cut Acceleron Pharma from a strong-buy rating to a buy rating in a research report on Thursday, April 18th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and eighteen have issued a buy rating to the company. The stock presently has a consensus rating of Buy and a consensus price target of $295.06.
Shares of NYSE:UNH traded down $0.31 on Friday, reaching $255.01. The company had a trading volume of 2,465,463 shares, compared to its average volume of 4,801,357. UnitedHealth Group has a twelve month low of $208.07 and a twelve month high of $287.94. The company has a quick ratio of 0.73, a current ratio of 0.67 and a debt-to-equity ratio of 0.62. The stock has a market cap of $243.91 billion, a PE ratio of 19.80, a P/E/G ratio of 1.37 and a beta of 0.62. The company has a 50-day moving average of $249.84.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, July 18th. The healthcare conglomerate reported $3.60 earnings per share for the quarter, topping the consensus estimate of $3.46 by $0.14. UnitedHealth Group had a return on equity of 25.20% and a net margin of 5.51%. The business had revenue of $60.60 billion during the quarter, compared to analysts’ expectations of $60.59 billion. During the same quarter in the previous year, the firm earned $3.14 EPS. The firm’s revenue was up 8.0% compared to the same quarter last year. On average, research analysts anticipate that UnitedHealth Group will post 14.81 EPS for the current year.
The company also recently declared a quarterly dividend, which was paid on Tuesday, June 25th. Shareholders of record on Monday, June 17th were issued a $1.08 dividend. This is a boost from UnitedHealth Group’s previous quarterly dividend of $0.90. The ex-dividend date was Friday, June 14th. This represents a $4.32 annualized dividend and a yield of 1.69%. UnitedHealth Group’s dividend payout ratio is 33.54%.
In other UnitedHealth Group news, Director Richard T. Burke sold 10,000 shares of the company’s stock in a transaction that occurred on Tuesday, June 11th. The stock was sold at an average price of $248.00, for a total value of $2,480,000.00. Following the completion of the transaction, the director now owns 187,663 shares of the company’s stock, valued at approximately $46,540,424. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CEO David S. Wichmann purchased 20,000 shares of the business’s stock in a transaction on Friday, May 3rd. The stock was purchased at an average cost of $231.79 per share, with a total value of $4,635,800.00. Following the acquisition, the chief executive officer now owns 904,367 shares in the company, valued at $209,623,226.93. The disclosure for this purchase can be found here. In the last ninety days, insiders sold 35,000 shares of company stock valued at $8,392,500. Insiders own 0.82% of the company’s stock.
Several hedge funds have recently added to or reduced their stakes in UNH. Canton Hathaway LLC bought a new stake in shares of UnitedHealth Group in the 1st quarter valued at approximately $36,000. Truvestments Capital LLC bought a new stake in shares of UnitedHealth Group in the 1st quarter valued at approximately $42,000. Creative Financial Designs Inc. ADV grew its stake in shares of UnitedHealth Group by 89.6% in the 1st quarter. Creative Financial Designs Inc. ADV now owns 201 shares of the healthcare conglomerate’s stock valued at $50,000 after purchasing an additional 95 shares during the period. Financial Gravity Wealth Inc. bought a new stake in shares of UnitedHealth Group in the 1st quarter valued at approximately $58,000. Finally, Horan Capital Advisors LLC. bought a new stake in shares of UnitedHealth Group in the 1st quarter valued at approximately $68,000. Institutional investors own 85.65% of the company’s stock.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Featured Story: What does a hold rating mean?
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.